About Rhenium Group

OUR JOURNEY

1991
Established
Rhenium was established in 1991 And started as a small company in Dror’s sister garage, to a successful, leading company in the heath care sector in Israel.
1991
1996
ThermoFisher (Invitrogen)
Along the way, we have established strong partnerships with our suppliers. delivering cutting-edge solutions that support groundbreaking research and diagnostic initiatives across the country
1996
2002
Beckman Coulter
The partnership with Beckman Coulter has a long-standing history, creating mutual value for the Israeli scientific and healthcare ecosystem. This collaboration has significantly contributed to advancements in various research and diagnostic fields, underscoring a shared commitment to innovation and excellence.
2002
2016
Rhenium Medical
Rhenium Medical was founded in a merger between the Rhenium company and the diagnostics division of Teva Medical. Rhenium Medical one of the leading diagnostic companies in Israel.
2016
2019
Oncotest & Eisenberg Bros.
Rhenium Acquired Oncotest.
Rhenium Acquires Eisenberg - positioned at the forefront of innovation in the Israeli Scientific ecosystem.
2019
2024
Today
started as a small company in Dror’s sister garage, to a successful, leading company in the health care sector in Israel, And in 2022, the second largest private equity in Israel- FORTISSIMO, acquired 50% of the company.
2024

OUR STORY

Welcome to Rhenium, your premier destination for cutting-edge laboratory, research, diagnostic, and personalized medicine solutions in Israel. As a trusted partner, we collaborate with industry leaders like Thermo Fisher Scientific, Beckman Coulter, Leica, Pall, Olympus, Abbott, and many others to bring innovative and professional solutions to our vast customer network, which spans over 15,000 clients.

At Rhenium, our mission is clear: we are dedicated to empowering our customers to achieve groundbreaking discoveries and advancements in healthcare. We achieve this by leading with innovation, providing expert knowledge-based solutions, and delivering best-in-class services to both our valued customers and esteemed suppliers.

With a commitment to excellence and a passion for pushing the boundaries of possibility, Rhenium is your partner of choice in driving progress and revolutionizing the future of healthcare. Join us on our journey towards innovation, discovery, and excellence.

MEET OUR OWNERS

The company is co-owned by the founder Dror Israeli and Fortissimo Capital

Dror Israeli, the visionary founder and chairman of Rhenium since 1991, has significantly transformed healthcare solutions in Israel. His dedication to excellence and innovation has positioned Rhenium as a premier supplier of state-of-the-art technologies and comprehensive solutions. Under his leadership, Rhenium has flourished, forming valuable partnerships with researchers, medical professionals, and industry authorities. Dror’s commitment to a culture of innovation encourages creativity, professional development, and team collaboration, driving the company to surpass expectations.

Fortissimo Capital, a prominent private equity fund in Israel, is known for its innovative approach to investments in technology and industrial companies. As co-owner of Rhenium, Fortissimo Capital’s expertise in business development and strategic planning aids Rhenium’s expansion and success. Their investment underscores a commitment to advancing healthcare solutions and aligns with Rhenium’s vision of revolutionizing healthcare through emerging technologies and personalized medicine.

MEET OUR MANAGEMENT TEAM

Eran Taus

Group CEO

Inbal Shaish

VP Rhenium Bio Science

Sivan Raz

VP Rhenium Medical

Lior Soussangutman

CEO Oncotest, VP Rhenium
Precision Medicine

Gal Israeli

CEO Eisenberg

Michal Raviv

CMO

Amir Shahar

CFO

Etai Yaffe

CTiO

Keren Levin

HR Director

Skip to content